CARDIOTAN HCT

This brand name is authorized in Nigeria.

Active ingredients

The drug CARDIOTAN HCT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 864V2Q084H - AMLODIPINE BESYLATE
 

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

 
Read more about Amlodipine
2
UNII U5SYW473RQ - TELMISARTAN
 

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.

 
Read more about Telmisartan
3
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
 

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.

 
Read more about Hydrochlorothiazide

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100789 Tablet Cardiotan HCT Tablet 80/10/12.5 mg TAB 10 mg; 80 mg; 12.5 mg 3 x 10's; 10 x 10's (in Alu-Alu blisters) Uncoated Tablet. Pink and white colored bilayered, round, biconvex tablet, having break line on one side and plain on other side 27/03/2024
A4-100790 Tablet Cardiotan HCT Tablet 40/5/12.5 mg TAB 5 mg; 40 mg; 12.5 mg 3 x 10's; 10 x 10's (in Alu-Alu blisters) Uncoated Tablet. Pink and white colored bilayered, round, biconvex tablets, both sides plain 27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09DX08 C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DX Angiotensin II antagonists, other combinations
Discover more medicines within C09DX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100789, A4-100790

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈